Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antianaphylaxis(antihistamines) and antidotes > Clomifene citrate 50-41-9

Clomifene citrate 50-41-9

Inquiry
  Post Date: Sep 06,2015
  Expiry Date: Sep 05,2016
  Detailed Description: Cas No. :50-41-9 Payment Method: L/C, T/T, D/P, Western Union
Another name:2-4-[2-Chloro-1,2-diphenylethenyl]phenoxy-N,N-diethylethanamine citrate
Structural formula: C26H28ClNO C6H8O7
Molecular weight: 598.11
CAS NO: 50-41-9
Appearance: white or milky white crystalline powder
Use: the goods to anti-estrogen fertility inducer, the objects in dysfunctional uterine bleeding, polycystic ovary, menstrual disorders and drug-induced amenorrhea and other gynecologic diseases
Standard: CP USP

  CAS Registry Number:

50-41-9
  Synonyms: ;clomiphene citrate;CLOMEPHENE CITRATE;Clomifene Citrate;2-(4-[2-Chloro-1,2-diphenylethenyl]phenoxy)-N,N-diethylethanamine citrate;2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-N,N-diethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (1:1);2-{4-[(Z)-2-chloro-1,2-diphenylethenyl]phenoxy}-N,N-diethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt);2-{4-[(E)-2-chloro-1,2-diphenylethenyl]phenoxy}-N,N-diethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt);
  Molecular Formula: C32H36ClNO8
  Molecular Weight: 598.0831
  Molecular Structure: 50-41-9 clomifene dihydroen citrate
  Hazard Symbols:  T:Toxic;
  Risk Codes: R60:;
R63:;
  Safety Description: S53:;
S36/37:;
S45:;

  Company: Saichuang Technology Co., Ltd.     [ China ]        
  Contact: Davidyang
  Tel: 008650755943
  Fax: 8602768886696
  Email: davidyang@ycphar.com
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.